Hairy cell leukaemia: review of treatment
- 1 October 1991
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 79 (s1) , 17-20
Abstract
The cardinal features of hairy cell leukaemia are: (i) cytopenias, (ii) splenomegaly, and (iii) mononuclear cells of B-cell origin with cytoplasmic projections and tartrate-resistant acid phosphatase-positivity. The most common complication is infection. In the past, the mainstay of therapy has been splenectomy, and this procedure is still often suggested as a first-line approach. However, research during the last decade has resulted in three new, highly effective therapies for hairy cell leukaemia: interferon-alpha (IFN-alpha), 2'-deoxycoformycin (DCF) and 2-chlorodeoxyadenosine (2CDA). IFN-alpha is currently approved for this indication. About 90% of patients have a durable haematologic recovery, and complete remission rates range from less than 5% to greater than 40% in different series. It should be noted that patients with partial remissions generally have normal or near-normal blood counts, and can live indefinitely without disease-related problems, despite a few remaining hairy cells in the bone marrow. In this paper we will discuss the various therapeutic modalities available for patients with hairy cell leukaemia.Keywords
This publication has 25 references indexed in Scilit:
- Treatment of hairy-cell leukemiaBlood Reviews, 1990
- Lasting Remissions in Hairy-Cell Leukemia Induced by a Single Infusion of 2-ChlorodeoxyadenosineNew England Journal of Medicine, 1990
- Durable complete remissions after 2′‐deoxycoformycin treatment in patients with hairy cell leukemia resistant to interferon alphaAmerican Journal of Hematology, 1990
- Recombinant interferon gamma in hairy cell leukemia, multiple myeloma, and Waldenstrom's macroglobulinemiaAmerican Journal of Hematology, 1988
- Treatment of hairy-cell leukaemia with α-interferon (α-IFN)European Journal of Cancer and Clinical Oncology, 1988
- FURTHER EVIDENCE OF THE EFFICACY OF INTERFERON FOR T‐CELL HAIRY CELL LEUKAEMIA: To the Editor:European Journal of Haematology, 1988
- Interferon-beta induced remission in a hairy cell leukemia patient resistant to interferon-alphaLeukemia Research, 1988
- Disseminated atypical mycobacterial infection in patients with hairy cell leukemiaThe American Journal of Medicine, 1986
- Infectious complications in 127 patients with hairy cell leukemiaAmerican Journal of Hematology, 1984
- Alpha Interferon for Induction of Remission in Hairy-Cell LeukemiaNew England Journal of Medicine, 1984